Breast Cancer Breakthrough
Published: April 19, 2006
There’s promising news for women at high risk of getting breast cancer. The osteoporosis drug, Raloxifene also known as Evista proved to be just as effective in preventing breast cancer as Tamoxifen, but with fewer side effects.
A study called *STAR* involved 20,000 women, including many from Western New York. Pat Dean, 66, participated. “If we can help my daughter, my granddaughter and any other women in the world, it’s worth it” said Dean.
The serious side effects of tamoxifen included uterine cancer and blood clots. “The concern regarding those side effects have really prevented many women from pursuing tamoxifen” according to Dr. Stephen Edge, Roswell Park Chief of Breast Surgery.
Doctors say by taking either drug does not eliminate a woman’s chance of getting breast cancer. The study demonstrates that the drugs can reduce the chance of getting breast cancer by one half, bit it’s not 100%.
If you enjoyed this good news Subscribe to Good News Blog
Share this
To share this simply copy and paste one of the below URL's: